Editorial
Medical cannabis articles for SA patients
Educational pieces on SA regulation, evidence, and practical guidance — written for patients researching the SAHPRA Section 21 medical cannabis pathway. No brand claims, no testimonials, no therapeutic guarantees — HPCSA Rule 27 compliant throughout.
regulation · private-vs-medical
What changed for medical cannabis under the Cannabis for Private Purposes Act 2024
The Cannabis for Private Purposes Act decriminalised adult private cultivation and use — but the medical pathway is a separate framework that did not change. Here is the practical distinction.
Last reviewed
process · timing · cost
SAHPRA Section 21 in 2026 — typical timelines, costs, and what to expect
A practical, current snapshot of what a patient should expect from intake assessment to medication in hand. End-to-end timing, cost breakdown, and what affects each step.
Last reviewed
cost · medical-aid · practical
Medical aid coverage of medical cannabis in SA — what schemes do and do not cover
Most SA medical schemes do not cover Section 21 medication itself. The doctor consultation may be partly claimable. Here is the current landscape and how to confirm with your scheme.
Last reviewed
clinical · first-line · application-prep
Why medical cannabis is not a first-line treatment — and what that means for your application
Cannabinoid therapy is rarely the first answer for any indication. Understanding why — and what "trialled first-line" actually requires — is the difference between an accepted Section 21 application and a declined one.
Last reviewed
regulation · compliance · transparency
How HPCSA Rule 27 shapes what doctors can and cannot tell you about cannabis
You may have noticed Docto24 never names specific products, never publishes patient testimonials, and avoids comparative claims. That is HPCSA Rule 27 in action — here is what the rule says and why it matters.
Last reviewed
regulation · cbd · scheduling
Cannabidiol (CBD) products in South Africa — Schedule 0 vs Section 21 explained
You can buy low-dose CBD over-the-counter in any SA pharmacy under Gazette 43347, but clinically relevant doses require Section 21 access. Here is the regulatory split, why it exists, and what it means for patients.
Last reviewed
safety · pregnancy · clinical
Medical cannabis and pregnancy — why the answer is no, and what alternatives exist
Cannabinoid therapy in pregnancy is consistently deferred by SA Section 21 prescribers. Here is the evidence basis for that position and what symptomatic alternatives exist for the relevant indications.
Last reviewed
safety · legal · practical
Driving on medical cannabis in South Africa — the National Road Traffic Act and your prescription
A SAHPRA Section 21 cannabis prescription does not exempt you from impairment laws. Here is what the National Road Traffic Act says, what your doctor will advise, and how to manage timing.
Last reviewed
process · consultation · telemedicine
What happens at a Docto24 telemedicine consultation — a step-by-step walkthrough
For patients who have never had a telemedicine consultation, the format can feel unfamiliar. Here is exactly what happens — what the doctor will ask, how decisions are made, and what to have ready.
Last reviewed
practical · travel · legal
International travel with Section 21 cannabis prescriptions — what works and what does not
A SAHPRA Section 21 authorisation is South African — it does not extend across borders. Here is what to know about travel within SA, regional travel in southern Africa, and intercontinental travel.
Last reviewed
Researching the practical mechanics? See our step-by-step Section 21 application guide — a structured walkthrough of the patient-side process.